Amundi Purchases 11,496 Shares of Balchem Co. (NASDAQ:BCPC)

Amundi boosted its stake in Balchem Co. (NASDAQ:BCPC - Free Report) by 151.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 19,096 shares of the basic materials company's stock after buying an additional 11,496 shares during the quarter. Amundi owned approximately 0.06% of Balchem worth $3,000,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of BCPC. Westside Investment Management Inc. bought a new position in shares of Balchem during the third quarter valued at about $27,000. R Squared Ltd purchased a new position in shares of Balchem in the 4th quarter worth approximately $29,000. Wilmington Savings Fund Society FSB bought a new position in shares of Balchem in the third quarter valued at approximately $35,000. Venturi Wealth Management LLC purchased a new position in Balchem in the fourth quarter worth $95,000. Finally, Smartleaf Asset Management LLC boosted its holdings in shares of Balchem by 230.8% in the 4th quarter. Smartleaf Asset Management LLC now owns 645 shares of the basic materials company's stock worth $106,000 after buying an additional 450 shares during the last quarter. 87.91% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several analysts have commented on the stock. Sidoti raised shares of Balchem to a "hold" rating in a research report on Tuesday, February 25th. HC Wainwright restated a "buy" rating and issued a $190.00 price objective on shares of Balchem in a research note on Monday, February 24th. Finally, StockNews.com lowered shares of Balchem from a "buy" rating to a "hold" rating in a research note on Tuesday, February 25th.

Remove Ads

Balchem Price Performance

NASDAQ:BCPC traded down $1.84 during mid-day trading on Thursday, reaching $163.40. The stock had a trading volume of 154,622 shares, compared to its average volume of 111,318. Balchem Co. has a one year low of $137.69 and a one year high of $186.03. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.16 and a current ratio of 1.99. The firm has a 50 day moving average price of $164.45 and a two-hundred day moving average price of $169.59. The stock has a market capitalization of $5.32 billion, a P/E ratio of 41.58, a P/E/G ratio of 4.41 and a beta of 0.63.

Balchem (NASDAQ:BCPC - Get Free Report) last announced its quarterly earnings data on Friday, February 21st. The basic materials company reported $1.03 earnings per share for the quarter, missing analysts' consensus estimates of $1.11 by ($0.08). Balchem had a return on equity of 11.37% and a net margin of 13.47%. The business had revenue of $240.00 million during the quarter, compared to the consensus estimate of $239.96 million. As a group, analysts expect that Balchem Co. will post 4.64 earnings per share for the current year.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.